Trials that use: P-values
New to this method? Read the tutorial →
10,701 results
- Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles: Complete Statistical AnalysisIndependent statistical analysis of Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Investigation of the Safety and Effectiveness of a Trifocal IOL: Complete Statistical AnalysisIndependent statistical analysis of Investigation of the Safety and Effectiveness of a Trifocal IOL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176965).
- Investigation of Trunk Muscle Size and Function in Older Adults With Chronic Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Trunk Muscle Size and Function in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Investigation of Wearing Compliance of Spectacles for Myopia Control: Complete Statistical AnalysisIndependent statistical analysis of Investigation of Wearing Compliance of Spectacles for Myopia Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06590441).
- Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment: Complete Statistical AnalysisIndependent statistical analysis of Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: Complete Statistical AnalysisIndependent statistical analysis of Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01574157).
- INVIGORATEIndependent statistical analysis of Exacerbation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845728).
- Involving Family to Improve Communication in Breast Cancer Care: Complete Statistical AnalysisIndependent statistical analysis of Involving Family to Improve Communication in Breast Cancer Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03283553).
- INVSENSOR00013 Respiratory Rate Clinical Performance Study: Complete Statistical AnalysisIndependent statistical analysis of INVSENSOR00013 Respiratory Rate Clinical Performance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03440619).
- IO Vancomycin in TSA: Complete Statistical AnalysisIndependent statistical analysis of IO Vancomycin in TSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05831774).
- ION-ASDIndependent statistical analysis of Oxytocin and Social Cognitive Skills Groups: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02918864).
- IONMIndependent statistical analysis of Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191282).
- IOOVIndependent statistical analysis of The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IOPAIndependent statistical analysis of A Study for Patients With Diabetes Mellitus (IOPA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420095).
- Iota-Carrageenan Nasal Spray in Common Cold: Complete Statistical AnalysisIndependent statistical analysis of Iota-Carrageenan Nasal Spray in Common Cold: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01944631).
- IPATunity130Independent statistical analysis of A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer:…
- IPCIndependent statistical analysis of Feasibility of an Integrated Patient Care (IPC) System Using Daily Filling Pressures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- IPF-201Independent statistical analysis of Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Ipilimumab and Local Radiation for Selected Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Ipilimumab and Local Radiation for Selected Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01769222).
- IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: Complete Statistical AnalysisIndependent statistical analysis of IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- iPOP-UPIndependent statistical analysis of Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05627011).
- IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: Complete Statistical AnalysisIndependent statistical analysis of IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: primary endpoint results,…
- Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction: primary endpoint results, effect estimate with confidence interval,…
- IRISComplete statistical analysis of the IRIS trial of pioglitazone versus placebo after stroke or myocardial infarction, including trial design, time-to-event endpoints, Cox modeling, mixed-effects analysis, multiplicity, interim analysis, results, and statistical interpretation.
- IRMAIndependent statistical analysis of Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00721188).
- Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: Complete Statistical AnalysisIndependent statistical analysis of Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: Complete Statistical AnalysisIndependent statistical analysis of Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02224625).
- Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: Complete Statistical AnalysisIndependent statistical analysis of Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510675).
- ISABELA1Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- ISABELA2Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- ISLANDIndependent statistical analysis of The ISLAND Study: InSuLa Assessed Needs for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02137369).
- Islet Transplantation for Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Islet Transplantation for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00014911).
- iSmartHypIndependent statistical analysis of The Smart Hypertension Control Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03288142).
- Isoflurane Preconditioning for Liver Resections: Complete Statistical AnalysisIndependent statistical analysis of Isoflurane Preconditioning for Liver Resections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01031550).
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ISS-DMIIIndependent statistical analysis of Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): Complete Statistical AnalysisIndependent statistical analysis of Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Itacitinib + Everolimus in Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib + Everolimus in Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03697408).
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: primary endpoint…
- iTAP-VIndependent statistical analysis of The Insomnia Treatment and Problems Study for Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03804788).
- iTBS Study for Depression (Randomized): Complete Statistical AnalysisIndependent statistical analysis of iTBS Study for Depression (Randomized): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03745768).
- ITPIndependent statistical analysis of Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00699140).
- iTransition Development: Complete Statistical AnalysisIndependent statistical analysis of iTransition Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04383223).
- ITUIndependent statistical analysis of ITU Treatment for Chronic Epicondylitis Musculoskeletal Pain Reduction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255733).